Literature DB >> 25956288

Establishing a reference range for thrombin generation using a standard plasma significantly improves assay precision.

C N Bagot1, E Leishman2.   

Abstract

BACKGROUND: Thrombin generation is a global coagulation assay which appears to be an effective method for assessing the potential for an individual's plasma to coagulate. However for this assay to become accepted in routine clinical practice it requires standardization.
OBJECTIVES: To establish a reference range for the NIBSC reference plasma (TGT-RP) which can then become an internal quality control (IQC) for thrombin generation assays. PATIENTS/
METHODS: Thrombin generation was measured in TGT-RP in 153 independent experiments using 4 assay conditions; 1 pM tissue factor (TF) or 5 pM TF +/- thrombomodulin (TM). A target value +/- 2 SD was calculated to provide an acceptance range under the 4 conditions. A plasma sample from a healthy volunteer was subsequently tested in 11 separate experiments using the TGT-RP for (i) normalisation and (ii) exclusion of experimental results when the TGT-RP results did not fall within the established acceptance range.
RESULTS: An acceptance range was established for TGT-RP for the 4 assay conditions. Normalisation of all results from a healthy volunteer reduced inter-assay variability significantly (ETP: p=0.0003; Peak: p=0.001). Exclusion of results from the volunteer when concurrently run TGT-RP results fell outside the acceptance range reduced inter-assay variability significantly when reporting raw data (ETP: p=0.001; Peak: p=0.004). However normalisation of this data had no beneficial effect (ETP: p=0.126; Peak: p=0.232).
CONCLUSIONS: Our work represents further progress in the standardization of thrombin generation techniques with the establishment of an IQC reference range. Using an IQC reduces inter-assay variability, whilst allowing reporting of raw data and ensures production of accurate and reproducible data.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Normalisation; Quality control; Reference range; Standard plasma; Standardisation; Thrombin generation assay

Mesh:

Substances:

Year:  2015        PMID: 25956288     DOI: 10.1016/j.thromres.2015.04.020

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP.

Authors:  Marcus Ljungkvist; Maria Berndtsson; Margareta Holmström; Danijela Mikovic; Ivo Elezovic; Jovan P Antovic; Eva Zetterberg; Erik Berntorp
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-11-01       Impact factor: 2.576

2.  Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.

Authors:  Despina Fotiou; Theodoros N Sergentanis; Loula Papageorgiou; Kimon Stamatelopoulos; Maria Gavriatopoulou; Efstathios Kastritis; Theodora Psaltopoulou; Stella Salta; Patrick Van Dreden; Rabiatou Sangare; Annette K Larsen; Evangelos Terpos; Ismail Elalamy; Meletios A Dimopoulos; Grigoris T Gerotziafas
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

3.  Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.

Authors:  Jonathan Douxfils; Laure Morimont; Céline Bouvy; Marie de Saint-Hubert; Bérangère Devalet; Célia Devroye; Anne-Sophie Dincq; Jean-Michel Dogné; Maïté Guldenpfennig; Justine Baudar; Anne-Sophie Larock; Sarah Lessire; François Mullier
Journal:  J Thromb Haemost       Date:  2019-05-31       Impact factor: 5.824

4.  Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study.

Authors:  Grigoris T Gerotziafas; Theodoros Zografos; Ioannis Pantos; Eleftheria Lefkou; Audrey Carlo; Jawed Fareed; Patrick Van Dreden; Demosthenes Katritsis
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 5.  Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.

Authors:  Karen S Brown; Hamim Zahir; Michael A Grosso; Hans J Lanz; Michele F Mercuri; Jerrold H Levy
Journal:  Crit Care       Date:  2016-09-23       Impact factor: 9.097

Review 6.  A review of commercially available thrombin generation assays.

Authors:  Jeremy Kintigh; Paul Monagle; Vera Ignjatovic
Journal:  Res Pract Thromb Haemost       Date:  2017-10-16

7.  Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.

Authors:  Sara Calzavarini; Justine Brodard; Claudia Quarroz; Livia Maire; Raphael Nützi; Jovana Jankovic; Laura C Rotondo; Evelyne Giabbani; Georg Martin Fiedler; Michael Nagler; Anne Angelillo-Scherrer
Journal:  Res Pract Thromb Haemost       Date:  2019-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.